Skip to main content

Table 2 Characteristics of the institutions (N = 47)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

  Institutions (N = 47) %
Public 38 80.8
WHO regions   
  Africa 28 59.6
  America 3 6.4
  Eastern Europe 9 19.1
  Pacifica 4 8.5
  South East Asia 3 6.4
Specialized human resources*   
  Hematologist and oncologist 21 44.7
  At least one hematologist or one oncologist 42 89.3
Research ability 12 25.5
Technical competency   
  Philadelphia or CD117 20 42.6
  Bone marrow biopsy or aspiration 7 14.9
  1. *At time institutions were approved for participation in GIPAP.
\